Suppr超能文献

通过尿蛋白质组分析鉴定 ADAM28 作为膀胱癌的生物标志物。

Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.

机构信息

Department of Chemical and Material Engineering, National Yulin University of Science and Technology, Taiwan.

出版信息

Biochem Biophys Res Commun. 2011 Aug 12;411(4):714-20. doi: 10.1016/j.bbrc.2011.07.010. Epub 2011 Jul 18.

Abstract

Human urine contains a large number of proteins and peptides (the urinary proteome). Global analysis of the human urinary proteome is important for understanding urinary tract diseases. Bladder cancer is the most common urological cancer with higher incidence rates in endemic areas of Blackfoot disease (BFD) in southern Taiwan. The aim of this study was to use the proteomic approach to establish urinary protein biomarkers of bladder cancer. ADAM28, identified by proteomic approaches and confirmed by Western blotting, showed significant differences compared with normal individuals, so it may be a biomarker of bladder cancer.

摘要

人体尿液中含有大量的蛋白质和肽(尿蛋白质组)。全面分析人体尿蛋白质组对于了解尿路疾病具有重要意义。膀胱癌是最常见的泌尿系统癌症,在台湾南部黑脚病(BFD)流行地区发病率较高。本研究旨在采用蛋白质组学方法建立膀胱癌的尿蛋白生物标志物。通过蛋白质组学方法鉴定并经 Western 印迹验证的 ADAM28 与正常个体相比有显著差异,因此可能是膀胱癌的一个生物标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验